Addressing the inter-individual variation in response to consumption of plant food bioactives: Towards a better understanding of their role in healthy aging and cardiometabolic risk reduction

Molecular Nutrition and Food Research

Volumn 61, Issue 6, 2017, Pages

  Manach, Claudine ^a   Milenkovic, Dragan ^a   Van de Wiele, Tom ^b   Rodriguez Mateos, Ana ^c   de Roos, Baukje ^d   Garcia Conesa, Maria Teresa ^e   Landberg, Rikard ^f,g   Gibney, Eileen R ^h   Heinonen, Marina ⁱ   Tomás Barberán, Francisco ^e   Morand, Christine ^a  

^a INRA and University of Auvergne   (France)

^b GHENT UNIVERSITY   (Belgium)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d ROWETT RESEARCH INSTITUTE   (United Kingdom)

^e RESEARCH GROUP ON QUALITY   (Spain)

^f SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^g KAROLINSKA INSTITUTE   (Sweden)

^h UNIVERSITY COLLEGE DUBLIN   (Ireland)

ⁱ UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Bioavailability and metabolism; Biological responsiveness; Cardiometabolic health; Inter individual variation; Plant food bioactives

Indexed keywords

PLANT MEDICINAL PRODUCT;

CARDIOVASCULAR DISEASE; CHEMISTRY; DIET; EDIBLE PLANT; HEALTH BEHAVIOR; HEALTHY AGING; HEALTHY DIET; HUMAN; METABOLIC DISORDER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; RISK REDUCTION;

CARDIOVASCULAR DISEASES; DIET; HEALTH BEHAVIOR; HEALTHY AGING; HEALTHY DIET; HUMANS; METABOLIC DISEASES; PHYTOCHEMICALS; PLANTS, EDIBLE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 85003674360     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201600557     Document Type: Review

References (88)

1. Willett, W. C., Koplan, J. P., Nugent, R., Dusenbury, C. et al., in: Jamison, D. T., Breman, J. G., Measham, A. R., Alleyne, G., et al. (Eds.), Disease Control Priorities in Developing Countries, World Bank. The International Bank for Reconstruction and Development/The World Bank Group, Washington (DC) 2006.
2. Boeing, H., Bechthold, A., Bub, A., Ellinger, S. et al., Critical review: vegetables and fruit in the prevention of chronic diseases. Eur. J. Nutr. 2012, 51, 637–663.
3. Carter, P., Gray, L. J., Troughton, J., Khunti, K. et al., Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ (Clinical research ed.) 2010, 341, c4229.
4. Nothlings, U., Schulze, M. B., Weikert, C., Boeing, H. et al., Intake of vegetables, legumes, and fruit, and risk for all-cause, cardiovascular, and cancer mortality in a European diabetic population. J. Nutr. 2008, 138, 775–781.
5. Wang, X., Ouyang, Y., Liu, J., Zhu, M. et al., Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ (Clinical research ed.) 2014, 349, g4490.
6. Crowe, F. L., Roddam, A. W., Key, T. J., Appleby, P. N. et al., Fruit and vegetable intake and mortality from ischaemic heart disease: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart study. Eur. Heart. J. 2011, 32, 1235–1243.
7. John, J. H., Ziebland, S., Yudkin, P., Roe, L. S. et al., Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial. Lancet 2002, 359, 1969–1974.
8. Macready, A. L., George, T. W., Chong, M. F., Alimbetov, D. S. et al., Flavonoid-rich fruit and vegetables improve microvascular reactivity and inflammatory status in men at risk of cardiovascular disease–FLAVURS: a randomized controlled trial. Am. J. Nutr. 2014, 99, 479–489.
9. McCall, D. O., McGartland, C. P., McKinley, M. C., Patterson, C. C. et al., Dietary intake of fruits and vegetables improves microvascular function in hypertensive subjects in a dose-dependent manner. Circulation. 2009, 119, 2153–2160.
10. Holst, B., Williamson, G., Nutrients and phytochemicals: from bioavailability to bioefficacy beyond antioxidants. Curr. Opin. Biotechnol. 2008, 19, 73–82.
11. Howes, M. J., Simmonds, M. S., The role of phytochemicals as micronutrients in health and disease. Curr. Opin. Clin. Nutr. Metab. Care 2014, 17, 558–566.
12. Ponzo, V., Goitre, I., Fadda, M., Gambino, R. et al., Dietary flavonoid intake and cardiovascular risk: a population-based cohort study. J. Transl. Med. 2015, 13, 218.
13. van Dam, R. M., Naidoo, N., Landberg, R., Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: review of recent findings. Curr. Opin. Lipidol. 2013, 24, 25–33.
14. Habauzit, V., Morand, C., Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: an update for clinicians. Ther. Adv. Chronic Dis. 2012, 3, 87–106.
15. Hooper, L., Kay, C., Abdelhamid, A., Kroon, P. A. et al., Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am. J. Clin. Nutr. 2012, 95, 740–751.
16. Hooper, L., Kroon, P. A., Rimm, E. B., Cohn, J. S. et al., Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2008, 88, 38–50.
17. EFSA, Scientific opinion on the substantiation of a health claim related to cocoa flavanols and maintenance of normal endothelium-dependent vasodilatation pursuant to Article 13(5) of Regulation (EC) No 1924/200. EFSA J. 2012, 10, 2809.
18. Andriantsitohaina, R., Auger, C., Chataigneau, T., Etienne-Selloum, N. et al., Molecular mechanisms of the cardiovascular protective effects of polyphenols. Brit. J. Nutr. 2012, 108, 1532–1549.
19. Declerck, K., Szarc vel Szic, K., Palagani, A., Heyninck, K. et al., Epigenetic control of cardiovascular health by nutritional polyphenols involves multiple chromatin-modifying writer-reader-eraser proteins. Curr. Topics Med. Chem. 2016, 16, 788–806.
20. Garcia-Conesa, M. T., Dietary polyphenols against metabolic disorders: how far have we progressed in the understanding of the molecular mechanisms of action of these compounds? Crit. Rev. Food. Sci. Nutr. 2015, DOI: 10.1080/10408398.2014.980499.
21. Ozdal, T., Sela, D. A., Xiao, J., Boyacioglu, D. et al., The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility. Nutrients 2016, 8, 1–36
22. Del Rio, D., Rodriguez-Mateos, A., Spencer, J. P., Tognolini, M. et al., Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxidants Redox Signaling 2013, 18, 1818–1892.
23. Maiani, G., Caston, M. J., Catasta, G., Toti, E. et al., Carotenoids: actual knowledge on food sources, intakes, stability and bioavailability and their protective role in humans. Mol. Nutr. Food Res. 2009, 53(Suppl 2), S194–218.
24. Verkerk, R., Schreiner, M., Krumbein, A., Ciska, E. et al., Glucosinolates in Brassica vegetables: the influence of the food supply chain on intake, bioavailability and human health. Mol. Nutr. Food Res. 2009, 53(Suppl 2), S219.
25. Manach, C., Scalbert, A., Morand, C., Remesy, C. et al., Polyphenols: food sources and bioavailability. Am. J. Clinical Nutr. 2004, 79, 727–747.
26. Duda-Chodak, A., Tarko, T., Satora, P., Sroka, P., Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review. Eur. J. Nutr. 2015, 54, 325–341.
27. Bolca, S., Possemiers, S., Maervoet, V., Huybrechts, I. et al., Microbial and dietary factors associated with the 8-prenylnaringenin producer phenotype: a dietary intervention trial with fifty healthy post-menopausal Caucasian women. Brit. J. Nutr. 2007, 98, 950–959.
28. Borel, P., Desmarchelier, C., Nowicki, M., Bott, R., Lycopene bioavailability is associated with a combination of genetic variants. Free Radic. Biol. Med. 2015, 83, 238–244.
29. Borel, P., Desmarchelier, C., Nowicki, M., Bott, R. et al., Interindividual variability of lutein bioavailability in healthy men: characterization, genetic variants involved, and relation with fasting plasma lutein concentration. Am. J. Clinical Nutr. 2014, 100, 168–175.
30. Gasper, A. V., Al-Janobi, A., Smith, J. A., Bacon, J. R. et al., Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli. Am. J. Clinical Nutr. 2005, 82, 1283–1291.
31. Gonzalez-Barrio, R., Borges, G., Mullen, W., Crozier, A., Bioavailability of anthocyanins and ellagitannins following consumption of raspberries by healthy humans and subjects with an ileostomy. J. Agricultural Food Chem. 2010, 58, 3933–3939.
32. Kuijsten, A., Arts, I. C., Vree, T. B., Hollman, P. C., Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside. J. Nutr. 2005, 135, 795–801.
33. Li, F., Hullar, M. A., Beresford, S. A., Lampe, J. W., Variation of glucoraphanin metabolism in vivo and ex vivo by human gut bacteria. Brit. J. Nutr. 2011, 106, 408–416.
34. Rodriguez-Mateos, A., Cifuentes-Gomez, T., Gonzalez-Salvador, I. et al., Influence of age on the absorption, metabolism, and excretion of cocoa flavanols in healthy subjects. Mol. Nutr. Food Res. 2015, 59, 1504–1512.
35. Selma, M. V., Romo-Vaquero, M., Garcia-Villalba, R., Gonzalez-Sarrias, A. et al., The human gut microbial ecology associated with overweight and obesity determines ellagic acid metabolism. Food Funct. 2016, 7, 1769–1774.
36. Setchell, K. D., Brown, N. M., Summer, S., King, E. C. et al., Dietary factors influence production of the soy isoflavone metabolite s-(-)equol in healthy adults. J. Nutr. 2013, 143, 1950–1958.
37. Setchell, K. D., Cole, S. J., Method of defining equol-producer status and its frequency among vegetarians. J. Nutr. 2006, 136, 2188–2193.
38. Song, K. B., Atkinson, C., Frankenfeld, C. L., Jokela, T. et al., Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J. Nutr. 2006, 136, 1347–1351.
39. Steck, S. E., Gammon, M. D., Hebert, J. R., Wall, D. E. et al., GSTM1, GSTT1, GSTP1, and GSTA1 polymorphisms and urinary isothiocyanate metabolites following broccoli consumption in humans. J. Nutr. 2007, 137, 904–909.
40. Tomas-Navarro, M., Vallejo, F., Sentandreu, E., Navarro, J. L. et al., Volunteer stratification is more relevant than technological treatment in orange juice flavanone bioavailability. J. Agricultural Food Chem. 2014, 62, 24–27.
41. Wang, T. T., Edwards, A. J., Clevidence, B. A., Strong and weak plasma response to dietary carotenoids identified by cluster analysis and linked to beta-carotene 15,15'-monooxygenase 1 single nucleotide polymorphisms. J. Nutritional Biochem. 2013, 24, 1538–1546.
42. Faulks, R. M., Southon, S., Challenges to understanding and measuring carotenoid bioavailability. Biochim. Biophys. Acta 2005, 1740, 95–100.
43. Borel, P., Genetic variations involved in interindividual variability in carotenoid status. Mol. Nutr. Food Res. 2012, 56, 228–240.
44. Ferrucci, L., Perry, J. R., Matteini, A., Perola, M. et al., Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. Am. J. Hum. Genet. 2009, 84, 123–133.
45. Filipski, K. K., Pacanowski, M. A., Ramamoorthy, A., Feero, W. G. et al., Dosing recommendations for pharmacogenetic interactions related to drug metabolism. Pharmacogenet Genomics 2016, 26, 334–339.
46. Hewett, M., Oliver, D. E., Rubin, D. L., Easton, K. L. et al., PharmGKB: the Pharmacogenetics Knowledge Base. Nucleic Acids Res. 2002, 30, 163–165.
47. Cornelis, M. C., El-Sohemy, A., Kabagambe, E. K., Campos, H., Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 2006, 295, 1135–1141.
48. Palatini, P., Ceolotto, G., Ragazzo, F., Dorigatti, F. et al., CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. J. Hypertension 2009, 27, 1594–1601.
49. Riso, P., Brusamolino, A., Moro, M., Porrini, M., Absorption of bioactive compounds from steamed broccoli and their effect on plasma glutathione S-transferase activity. Int. J. Food Sci. Nutr. 2009, 60(Suppl 1), 56–71.
50. Lampe, J. W., Interindividual differences in response to plant-based diets: implications for cancer risk. Am. J. Clinical Nutr. 2009, 89, 1553S–1557S.
51. Liu, Z. M., Ho, S. C., Chen, Y. M., Liu, J. et al., Cardiovascular risks in relation to daidzein metabolizing phenotypes among Chinese postmenopausal women. PLoS One 2014, 9, e87861.
52. Zhang, X., Gao, Y. T., Yang, G., Li, H. et al., Urinary isoflavonoids and risk of coronary heart disease. Internat. J. Epidemiol. 2012, 41, 1367–1375.
53. Hazim, S., Curtis, P. J., Schar, M. Y., Ostertag, L. M. et al., Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial. Am. J. Clinical Nutr. 2016, 103, 694–702.
54. Clavel, T., Desmarchelier, C., Haller, D., Gerard, P. et al., Intestinal microbiota in metabolic diseases: from bacterial community structure and functions to species of pathophysiological relevance. Gut Microbes 2014, 5, 544–551.
55. Hullar, M. A., Lancaster, S. M., Li, F., Tseng, E. et al., Enterolignan-producing phenotypes are associated with increased gut microbial diversity and altered composition in premenopausal women in the United States. Cancer Epidemiol. Biomarkers Prev. 2015, 24, 546–554.
56. Espin, J. C., Larrosa, M., Garcia-Conesa, M. T., Tomas-Barberan, F., Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far. Evidence-based Complementary Alternative Med. 2013, 2013, 270418.
57. Landete, J. M., Updated knowledge about polyphenols: functions, bioavailability, metabolism, and health. Crit. Rev. Food Sci. Nutr. 2012, 52, 936–948.
58. Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D. et al., Enterotypes of the human gut microbiome. Nature 2011, 473, 174–180.
59. Tomas-Barberan, F. A., Andres-Lacueva, C., Polyphenols and health: current state and progress. J. Agricultural Food Chem. 2012, 60, 8773–8775.
60. Bolca, S., Van de Wiele, T., Possemiers, S., Gut metabotypes govern health effects of dietary polyphenols. Curr. Opin. Biotechnol. 2013, 24, 220–225.
61. Dellinger, R. W., Garcia, A. M., Meyskens, F. L., Jr., Differences in the glucuronidation of resveratrol and pterostilbene: altered enzyme specificity and potential gender differences. Drug Metab. Pharmacokinet. 2014, 29, 112–119.
62. Mangoni, A. A., Jackson, S. H., Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br. J. Clin. Pharmacol. 2004, 57, 6–14.
63. Moco, S., Martin, F. P., Rezzi, S., Metabolomics view on gut microbiome modulation by polyphenol-rich foods. J. Proteome Res. 2012, 11, 4781–4790.
64. Kreijkamp-Kaspers, S., Kok, L., Bots, M. L., Grobbee, D. E. et al., Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. Am. J. Clinical Nutr. 2005, 81, 189–195.
65. Ostertag, L. M., Kroon, P. A., Wood, S., Horgan, G. W. et al., Flavan-3-ol-enriched dark chocolate and white chocolate improve acute measures of platelet function in a gender-specific way–a randomized-controlled human intervention trial. Mol. Nutr. Food Res. 2013, 57, 191–202.
66. Wilson, P. W., D'Agostino, R. B., Levy, D., Belanger, A. M. et al., Prediction of coronary heart disease using risk factor categories. Circulation. 1998, 97, 1837–1847.
67. Heiss, C., Sansone, R., Karimi, H., Krabbe, M. et al., Impact of cocoa flavanol intake on age-dependent vascular stiffness in healthy men: a randomized, controlled, double-masked trial. Age (Dordr) 2015, 37, 9794.
68. Fisher, N. D., Hollenberg, N. K., Aging and vascular responses to flavanol-rich cocoa. J. Hypertension 2006, 24, 1575–1580.
69. Egert, S., Bosy-Westphal, A., Seiberl, J., Kurbitz, C. et al., Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Brit. J. Nutr. 2009, 102, 1065–1074.
70. Jones, P. J., Inter-individual variability in response to plant sterol and stanol consumption. J AOAC Int. 2015, 98, 724–728.
71. Rideout, T. C., Harding, S. V., Mackay, D. S., Metabolic and genetic factors modulating subject specific LDL-C responses to plant sterol therapy. Canadian J. Physiol. Pharmacol. 2012, 90, 509–514.
72. De Castro-Oros, I., Pampin, S., Cofan, M., Mozas, P. et al., Promoter variant -204A >C of the cholesterol 7alpha-hydroxylase gene: association with response to plant sterols in humans and increased transcriptional activity in transfected HepG2 cells. Clin. Nutr. 2011, 30, 239–246.
73. Boon, R. A., Jae, N., Holdt, L., Dimmeler, S., Long Noncoding RNAs: from clinical genetics to therapeutic targets? J. Am. College Cardiol. 2016, 67, 1214–1226.
74. Samanta, S., Balasubramanian, S., Rajasingh, S., Patel, U. et al., MicroRNA: a new therapeutic strategy for cardiovascular diseases. Trends Cardiovasc. Med. 2016, 26, 407–419.
75. Voelter-Mahlknecht, S., Epigenetic associations in relation to cardiovascular prevention and therapeutics. Clin. Epigenetics 2016, 8, 4.
76. Milenkovic, D., Jude, B., Morand, C., miRNA as molecular target of polyphenols underlying their biological effects. Free. Radic. Biol. Med. 2013, 64, 40–51.
77. Crescenti, A., Sola, R., Valls, R. M., Caimari, A. et al., Cocoa consumption alters the global DNA methylation of peripheral leukocytes in humans with cardiovascular disease risk factors: a randomized controlled trial. PLoS One 2013, 8, e65744.
78. Tome-Carneiro, J., Larrosa, M., Yanez-Gascon, M. J., Davalos, A. et al., One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacol. Res. 2013, 72, 69–82.
79. Corella, D., Carrasco, P., Sorli, J. V., Estruch, R. et al., Mediterranean diet reduces the adverse effect of the TCF7L2-rs7903146 polymorphism on cardiovascular risk factors and stroke incidence: a randomized controlled trial in a high-cardiovascular-risk population. Diabetes. Care. 2013, 36, 3803–3811.
80. Palmer, N. D., Hester, J. M., An, S. S., Adeyemo, A. et al., Resequencing and analysis of variation in the TCF7L2 gene in African Americans suggests that SNP rs7903146 is the causal diabetes susceptibility variant. Diabetes. 2011, 60, 662–668.
81. Milenkovic, D., Deval, C., Dubray, C., Mazur, A. et al., Hesperidin displays relevant role in the nutrigenomic effect of orange juice on blood leukocytes in human volunteers: a randomized controlled cross-over study. PLoS One 2011, 6, e26669.
82. Tome-Carneiro, J., Gonzalvez, M., Larrosa, M., Yanez-Gascon, M. J. et al., Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease. Cardiovasc. Drugs Ther. 2013, 27, 37–48.
83. Manach, C., Hubert, J., Llorach, R., Scalbert, A., The complex links between dietary phytochemicals and human health deciphered by metabolomics. Mol. Nutr. Food Res. 2009, 53, 1303–1315.
84. Scalbert, A., Brennan, L., Manach, C., Andres-Lacueva, C. et al., The food metabolome: a window over dietary exposure. Am. J. Clinical Nutr. 2014, 99, 1286–1308.
85. Franke, A. A., Lai, J. F., Halm, B. M., Pagano, I. et al., Equol production changes over time in postmenopausal women. J. Nutritional Biochem. 2012, 23, 573–579.
86. Katz, D. L., Meller, S., Can we say what diet is best for health? Annu. Rev. Public. Health. 2014, 35, 83–103.
87. Hall, J. N., Moore, S., Harper, S. B., Lynch, J. W., Global variability in fruit and vegetable consumption. Am. J. Preventive Med. 2009, 36, 402–409.e405.
88. Bock, A., Maragkoudakis, P., Wollgast, J., Caldeira, S. et al., Joint Research Center Foresight Study - Tomorrow's Healthy Society - Research Priorities for Foods and Diets (Final Report). Publications Office European Union 2014, 1–66, DOI: 10.2788/14108.